Related Experiment Videos
Colonic epithelial miR-31 associates with the development of Crohn's phenotypes
Benjamin P Keith1,2, Jasmine B Barrow2, Takahiko Toyonaga2
1Curriculum in Bioinformatics and Computational Biology.
JCI Insight
|October 5, 2018
Summary
MicroRNA-31 (miR-31) levels in colon tissue identify distinct Crohn's disease subtypes. Low miR-31 expression is linked to worse outcomes in both adult and pediatric Crohn's disease patients.
Area of Science:
- Gastroenterology
- Molecular Biology
- Genetics
Background:
- Crohn's disease (CD) exhibits significant heterogeneity, complicating treatment strategies.
- Understanding the cellular mechanisms driving CD heterogeneity is crucial for developing effective therapies.
Purpose of the Study:
- To investigate the role of microRNA-31 (miR-31) in driving molecular subtypes of Crohn's disease.
- To correlate miR-31 expression levels with clinical features and disease outcomes in CD patients.
Main Methods:
- Small RNA sequencing was performed on adult colon tissue and pediatric biopsies from CD patients and controls.
- Colonic epithelial and immune cells were isolated, and miR-31 expression was quantified.
- Colonoid cultures were used to assess ex vivo miR-31 expression patterns.
Main Results:
- Two distinct molecular subtypes of CD were identified based on microRNA profiling.
- miR-31 expression was found to be a key driver of these subtypes, particularly in epithelial cells.
- Low colonic miR-31 expression in adults correlated with increased need for ileostomy and disease recurrence.
- In pediatric patients, lower miR-31 expression at diagnosis predicted future fibrostenotic ileal CD requiring surgery.
Conclusions:
- miR-31 expression serves as a biomarker for distinct CD subtypes and disease progression.
- These findings offer a foundation for developing personalized CD therapies and improving clinical trial design.